11 completed, 3 unknown, 1 enrolling by invitation, 1 not yet recruiting. 18 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 18 | Completed 11, Unknown 3, Enrolling by invitation 1, Not yet recruiting 1, Terminated 1, Withdrawn 1 |
Follow Attention Deficit and Disruptive Behavior Disorders: new trials by email Literature Review of Attention Deficit and Disruptive Behavior Disorders trials Research Report on Attention Deficit and Disruptive Behavior Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating the Efficacy of Atomoxetine in Reducing Primary Nocturnal Enuresis in Children With ADHD: A Randomized, Placebo-Controlled Study Atomoxetine, Placebo - ADHD, Primary Nocturnal Enuresis | Early Phase 1 | Not yet recruiting | Tanta University | 100 | 2025-02-28 | 2025-02-27 |
| Psychoneuromentalism Disorder: A Medical Condition That Affects People With Psychological Impairments From Health Issues Decompartmentalization Framework, Liquid Herbal TInctures, Mental Imagery - Schizoaffective Disorder, Bipolar Type, Bipolar Disorder | Early Phase 1 | Unknown | The Essence of Integrative Health and Medicine Practice | 30 | 2024-10-10 | 2024-08-12 |
| Reducing Disparities in Access to Evidence-Based Services for Attention Deficit Hyperactivity Disorder (ADHD) Through Technology Collaborative Life Skills - Control Condition, Intervention Condition | Early Phase 1 | Enrolling by invitation | San Diego State University | 350 | 2024-09-01 | 2026-04-13 |
| Methylphenidate and Response to Alcohol Cues Pilot Study Methylphenidate Pill - Alcohol Use Disorder, Attention Deficit Hyperactivity Disorder | Early Phase 1 | Completed | University of Florida | 31 | 2024-03-20 | 2026-02-10 |
| Relapse Prevention in Stimulant Use Disorder Contrave 8Mg-90Mg Extended-Release Tablet, Bupropion - Stimulant Use, Relapse | Early Phase 1 | Withdrawn | University of California, Los Angeles | 2023-06-11 | 2023-09-22 | |
| Mindfulness-Based ADHD Treatment for Children: a Feasibility Study Mindfulness-Based ADHD Treatment for Children, Goal-Standard Medication (Treatment as Usual) - Attention Deficit Hyperactivity Disorder | Early Phase 1 | Completed | Yale University | 68 | 2021-02-01 | 2024-11-25 |
| Prevalence of Lidocaine Ineffectiveness in Adults With and Without ADHD Lidocaine gel - ADHD, PMS | Early Phase 1 | Completed | PhenoSolve, LLC | 90 | 2019-08-14 | 2022-10-06 |
| Validating a New Non-invasive Approach to Testing Lidocaine Effectiveness Lidocaine gel, Placebo, Injected lidocaine - ADHD, Controls | Early Phase 1 | Completed | PhenoSolve, LLC | 20 | 2019-08-01 | 2020-07-15 |
| Effects of L-theanine and Caffeine on Attention and Attention-related Brain Activity of Children With Attention Deficit Hyperactivity Disorder L-theanine, Caffeine, L-theanine-Caffeine Combination - Attention Deficit Hyperactivity Disorder | Early Phase 1 | Completed | Texas Tech University | 6 | 2018-05-14 | 2019-04-12 |
| Observational Study to Assess the Frequency of Lidocaine Ineffectiveness in Hard-to-treat ADHD Lidocaine gel - ADHD | Early Phase 1 | Completed | PhenoSolve, LLC | 28 | 2018-01-20 | 2021-07-02 |
| Oxytocin and Cognitive Control in Adult ADHD Oxytocin nasal spray, Placebo nasal spray - Attention Deficit/Hyperactivity Disorder | Early Phase 1 | Completed | Massachusetts General Hospital | 24 | 2017-12-14 | 2024-05-03 |
| Eye Tracking as a Predictor of Methylphenidate Response in Autism With ADHD Methylphenidate, Placebo - Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder | Early Phase 1 | Completed | Children's Hospital Medical Center, Cincinnati | 40 | 2016-02-19 | 2021-01-15 |
| Neurocognitive and Neurobiological Improvement in ADHD Children With High Protein Diet BP22042013, Low carbohydrate diet - ADD, ADHD | Early Phase 1 | Completed | Spanish Foundation for Neurometrics Development | 100 | 2015-06-01 | 2021-04-08 |
| The Correlation Between Blood omega3 and ADHD blood test, omega3 capsules - Attention Deficit Hyperactivity Disorder (ADHD) | Early Phase 1 | Unknown | Ayelet Omer Armon | 60 | 2015-04-01 | 2015-03-19 |
| Neurocognitive and Neurobiological Improvement in ADHD Children by Modification of Dietary Protein BP22042013, Low carbohydrate diet - ADD, ADHD | Early Phase 1 | Completed | Spanish Foundation for Neurometrics Development | 64 | 2013-12-01 | 2024-05-08 |
| Amiloride Hydrochloride as an Effective Treatment for ADHD amiloride, Behavioral - ADHD | Early Phase 1 | Terminated | State University of New York - Upstate Medical University | 3 | 2012-09-01 | 2018-07-20 |
| Trigeminal Nerve Stimulation for Attention Deficit Hyperactivity Disorder (ADHD) EMS 7500 Digital Muscle Stimulator - Attention-Deficit/Hyperactivity Disorder | Early Phase 1 | Completed | University of California, Los Angeles | 25 | 2011-07-01 | 2016-04-11 |
| Procedural Learning in Participants With ADHD Methylphenidate - Attention Deficit Hyperactivity Disorder | Early Phase 1 | Unknown | Shaare Zedek Medical Center | 2007-03-13 |
Attention Deficit Disorder with Hyperactivity (18) · Alcoholism (1) · Anxiety Disorders (1) · Autism Spectrum Disorder (1) · Bipolar Disorder (1) · Dementia (1) · Disease (1) · Dissociative Disorders (1) · Emotional Regulation (1) · Fatigue (1) · Fatigue Syndrome, Chronic (1) · Impulsive Behavior (1) · Psychological Well-Being (1) · Psychotic Disorders (1) · Recurrence (1)
Mental Disorders (18) · Neurodevelopmental Disorders (18) · Behavior (3) · Disease Attributes (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Alcohol-Related Disorders (1) · Bipolar and Related Disorders (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Chemically-Induced Disorders (1) · Child Development Disorders, Pervasive (1) · Chronic Disease (1) · Encephalomyelitis (1)
Methods (3) · Methylphenidate (3) · Diet, Carbohydrate-Restricted (2) · Amiloride (1) · Atomoxetine Hydrochloride (1) · Breathing Exercises (1) · Bupropion (1) · Caffeine (1) · Dietary Supplements (1) · Docosahexaenoic Acids (1) · Hematologic Tests (1) · Meditation (1) · Mindfulness (1) · Music Therapy (1) · Therapeutics (1)
PhenoSolve, LLC (3) · Spanish Foundation for Neurometrics Development (2) · University of California, Los Angeles (2) · Ayelet Omer Armon (1) · Children's Hospital Medical Center, Cincinnati (1) · Massachusetts General Hospital (1) · San Diego State University (1) · Shaare Zedek Medical Center (1) · State University of New York - Upstate Medical University (1) · Tanta University (1) · Texas Tech University (1) · The Essence of Integrative Health and Medicine Practice (1) · University of Florida (1) · Yale University (1)
United States (12) · Israel (1) · United Kingdom (1)
Michael Segal, MD PhD (3) · Chanaka Kahathuduwa, MBBS PhD (1) · Edythe D London, Ph.D. (1) · Elizabeth A Lawson, MD (1) · Ernest Pedapati, MD (1) · Esther Adi-Japha, PhD (1) · Faith A Richardson, BSW, MPA, PhD (1) · Hedy Kober, PhD (1) · James J McGough, M.D. (1) · Linda Pfiffner, PhD (1) · Miguel Villodas, PhD (1) · Moises Aguilar-Domingo, PhD (1) · Prashant Kaul, MD (1) · Ruth Shalev, MD (1) · Stephen V Faraone, PhD (1)
PMID 11143733, PMID 18174562, PMID 18426576, PMID 23134619, PMID 24761279, PMID 24938135, PMID 25447751, PMID 9212254
R34AT009887 (1), U54MD012397 (1)